SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis

Oncogene

Volumn 30, Issue 37, 2011, Pages 3967-3978

  Lind, G E ^a,b   Raiborg, C ^b,c   Danielsen, S A ^a,b   Rognum, T O ^a,b   Thiis Evensen, E ^a   Hoff, G ^d   Nesbakken, A ^b,e   Stenmark, H ^b,c   Lothe, R A ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d TELEMARK HOSPITAL   (Norway)

^e AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

colorectal neoplasia; cytokinesis; early detection; methylation; SP; Spartin

Indexed keywords

MESSENGER RNA; SPARTIN PROTEIN; SPASTIC PARAPLEGIA 20; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CARCINOGENESIS; CELL CYCLE ARREST; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOKINESIS; DNA METHYLATION; DOWN REGULATION; FECES; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MUCOSA; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL;

EID: 85027949861     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.109     Document Type: Article

References (46)

1. Bakowska JC, Jenkins R, Pendleton J, Blackstone C. (2005). The Troyer syndrome (SPG20) protein spartin interacts with Eps15. Biochem Biophys Res Commun 334: 1042-1048. (Pubitemid 41074680)
2. Bakowska JC, Jupille H, Fatheddin P, Puertollano R, Blackstone C. (2007). Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking. Mol Biol Cell 18: 1683-1692. (Pubitemid 46717550)
3. Bakowska JC, Wang H, Xin B, Sumner CJ, Blackstone C. (2008). Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism? Arch Neurol 65: 520-524. (Pubitemid 351549962)
4. Bu Y, Yang Z, Li Q, Song F. (2008). Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. Oncology 74: 198-206.
5. Cabezas A, Bache KG, Brech A, Stenmark H. (2005). Alix regulates cortical actin and the spatial distribution of endosomes. J Cell Sci 118: 2625-2635. (Pubitemid 40932888)
6. Carmena M, Earnshaw WC. (2003). The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 4: 842-854. (Pubitemid 37411723)
7. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L et al. (2005). Detection in fecal DNA of colon cancer-specific methyl-ation of the nonexpressed vimentin gene. J Natl Cancer Inst 97: 1124-1132. (Pubitemid 41511211)
8. Ciccarelli FD, Proukakis C, Patel H, Cross H, Azam S, Patton MA et al. (2003). The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia. Genomics 81: 437-441. (Pubitemid 36379166)
9. Connell JW, Lindon C, Luzio JP, Reid E. (2009). Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion. Traffic 10: 42-56.
10. Devos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J et al. (2009). Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55: 1337-1346.
11. Eastman SW, Yassaee M, Bieniasz PD. (2009). A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. J Cell Biol 184: 881-894.
12. Edwards TL, Clowes VE, Tsang HT, Connell JW, Sanderson CM, Luzio JP et al. (2009). Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5. Biochem J 423: 31-39.
13. Errico A, Claudiani P, D'Addio M, Rugarli EI. (2004). Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum Mol Genet 13: 2121-2132. (Pubitemid 39377834)
14. Feinberg AP, Ohlsson R, Henikoff S. (2006). The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21-33. (Pubitemid 41828945)
15. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592. (Pubitemid 46359643)
16. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. (2005). Cytokinesis failure generating tetraploids promotes tumor-igenesis in p53-null cells. Nature 437: 1043-1047. (Pubitemid 41486987)
17. Ganem NJ, Storchova Z, Pellman D. (2007). Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17: 157-162. (Pubitemid 46551722)
18. Goh L, Murphy SK, Muhkerjee S, Furey TS. (2007). Genomic sweeping for hypermethylated genes. Bioinformatics 23: 281-288. (Pubitemid 46323149)
19. Hazan J, Fonknechten N, Mavel D, Paternotte C, Samson D, Artiguenave F et al. (1999). Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 23: 296-303. (Pubitemid 29526426)
20. Hooper C, Puttamadappa SS, Loring Z, Shekhtman A, Bakowska JC. (2010). Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets. BMC Biol 8: 72.
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009). Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
22. Jones PA, Baylin SB. (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428. (Pubitemid 34587077)
23. Kim MS, Lee J, Sidransky D. (2010). DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29: 181-206.
24. Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A et al. (2009). Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays. PLoS ONE 4: e4830.
25. Lengauer C, Kinzler KW, Vogelstein B. (1997). Genetic instability in colorectal cancers. Nature 386: 623-627. (Pubitemid 27175430)
26. Lind GE, Ahlquist T, Lothe RA. (2007). DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors. Gastroenterology 132: 1631-1632. (Pubitemid 46656256)
27. Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO et al. (2006). ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumor-igenesis. Cell Oncol 28: 259-272. (Pubitemid 44950097)
28. Lu J, Rashid F, Byrne PC. (2006). The hereditary spastic paraplegia protein spartin localises to mitochondria. J Neurochem 98: 1908-1919. (Pubitemid 44298254)
29. Milewska M, McRedmond J, Byrne PC. (2009). Identification of novel spartin-interactors shows spartin is a multifunctional protein. J Neurochem 111: 1022-1030.
30. Muller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M et al. (2004). Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363: 1283-1285. (Pubitemid 38496491)
31. Murata-Hori M, Tatsuka M, Wang YL. (2002). Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis. Mol Biol Cell 13: 1099-1108. (Pubitemid 34309608)
32. Patel H, Cross H, Proukakis C, Hershberger R, Bork P, Ciccarelli FD et al. (2002). SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat Genet 31: 347-348. (Pubitemid 35154441)
33. Pointis G, Gilleron J, Carette D, Segretain D. (2010). Physiological and physiopathological aspects of connexins and communicating gap junctions in spermatogenesis. Philos Trans R Soc Lond B Biol Sci 365: 1607-1620.
34. Proukakis C, Cross H, Patel H, Patton MA, Valentine A, Crosby AH. (2004). Troyer syndrome revisited. A clinical and radiological study of a complicated hereditary spastic paraplegia. J Neurol 251: 1105-1110. (Pubitemid 39297207)
35. Renvoise B, Parker RL, Yang D, Bakowska JC, Hurley JH, Blackstone C. (2010). SPG20 protein spartin is recruited to midbodies by ESCRT-III protein Ist1 and participates in cytokinesis. Mol Biol Cell 21: 3293-3303.
36. Robay D, Patel H, Simpson MA, Brown NA, Crosby AH. (2006). Endogenous spartin, mutated in hereditary spastic paraplegia, has a complex subcellular localization suggesting diverse roles in neurons. Exp Cell Res 312: 2764-2777. (Pubitemid 44262352)
37. Sagona AP, Nezis IP, Pedersen NM, Liestol K, Poulton J, Rusten TE et al. (2010). PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat Cell Biol 12: 362-371.
38. Sagona AP, Stenmark H. (2010). Cytokinesis and cancer. FEBS Lett 584: 2652-2661.
39. Simonsen A, Bremnes B, Ronning E, Aasland R, Stenmark H. (1998). Syntaxin-16, a putative Golgi t-SNARE. Eur J Cell Biol 75: 223-231. (Pubitemid 28174645)
40. Steigemann P, Gerlich DW. (2009). Cytokinetic abscission: cellular dynamics at the midbody. Trends Cell Biol 19: 606-616.
41. Steigemann P, Wurzenberger C, Schmitz MH, Held M, Guizetti J, Maar S et al. (2009). Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 136: 473-484.
42. Tsang HT, Edwards TL, Wang X, Connell JW, Davies RJ, Durrington HJ et al. (2009). The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet 18: 3805-3821.
43. Ventela S, Toppari J, Parvinen M. (2003). Intercellular organelle traffic through cytoplasmic bridges in early spermatids of the rat: mechanisms of haploid gene product sharing. Mol Biol Cell 14: 2768-2780. (Pubitemid 36871520)
44. Vidulescu C, Clejan S, O'connor KC. (2004). Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells. J Cell Mol Med 8: 388-396. (Pubitemid 44145502)
45. Zhang W, Bauer M, Croner RS, Pelz JO, Lodygin D, Hermeking H et al. (2007). DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum 50: 1618-1626. (Pubitemid 47583343)
46. Zitt M, Zitt M, Muller HM. (2007). DNA methylation in colorectal cancer-impact on screening and therapy monitoring modalities? Dis Markers 23: 51-71. (Pubitemid 46333641)